Used ASCVD Risk Estimator for iOS?


ASCVD Risk Estimator Analysis

AI Assisted Content ·

Not written by CNET Staff.

The ASCVD Risk Estimator is an educational app designed for iPhone users, focusing on assessing cardiovascular disease risk. This free application, developed by the American College of Cardiology, provides users with a tool to estimate the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) based on various health parameters, including age, gender, cholesterol levels, blood pressure, and smoking status. Its intuitive interface allows for easy input of personal health information, making it accessible for both healthcare professionals and individuals interested in monitoring their cardiovascular health.

Top Recommended Alternative

The app is compatible with iOS 16.4 and above, ensuring that users with recent iPhone models can utilize its features. Version 6.1 is currently available, and the application is exclusively in English. As a health and fitness software, it serves as a valuable resource for understanding personal risk factors and encourages proactive health management. Users can easily navigate through the app to gain insights into their cardiovascular health and make informed lifestyle choices.

Enlarged image for ASCVD Risk Estimator
ASCVD Risk Estimator 0/1

Used ASCVD Risk Estimator for iOS?


Explore More


Full Specifications

GENERAL
Release
Latest update
Version
7.6
OPERATING SYSTEMS
Platform
iOS
Operating System
iOS 16.4
POPULARITY
Total Downloads
28
Downloads Last Week
0

Report Software

Program available in other languages


Last Updated


Developer’s Description

The ASCVD Risk Estimator is published jointly by the American College of Cardiology (ACC) and the American Heart Association (AHA) to help health...

Download.com
Your review for ASCVD Risk Estimator
Download.com

AI Assisted Content Disclosure

Content created and reviewed by Softonic with information obtained from American College of Cardiology, using AI.

CNET's editorial team was not involved in the creation of this content. Opinions, analysis and reviews were not provided by CNET.